- recruitingPHASE1
Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
This study looks at how a new medicine, leramistat, interacts with other common medicines in healthy adults. It's an early-stage study to make sure it's safe to take with other treatments. Participants will take leramistat and other drugs to see how their bodies handle them.
United Kingdom - recruiting
Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment
This study at Imperial College Healthcare NHS Trust checks if antibiotics are reaching the right levels in patients with infections. It aims to improve how we use antibiotics to treat infections effectively and safely, and reduce the risk of antibiotic resistance.
United Kingdom - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Study is designed to assess the safety and tolerability of ceralasertib at increasing doses in combination with other anti-cancer treatment in patients with advanced tumours
This study is testing a new cancer drug called ceralasertib. It's for people with advanced cancer and aims to see how safe it is and if it causes side effects when given with other cancer treatments. Researchers are looking at different doses to find the best way to use it.
France